{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:16:01Z","timestamp":1789791361994,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      Norepinephrine has recently been suggested to be as effective as phenylephrine for the prevention of hypotension after spinal anesthesia for cesarean delivery. Moreover, compared to phenylephrine, norepinephrine may be superior in maintaining heart rate (HR) and consequently, cardiac output (CO). A recent study demonstrated that norepinephrine given as a single intravenous bolus is approximately 13 times more potent than phenylephrine. However, it is uncertain whether this finding can be applied when these vasopressors are administered as infusions. Therefore, the optimum infusion rate of norepinephrine remains unknown. We aimed to determine the median effective dose (ED\n                      <jats:sub>50<\/jats:sub>\n                      ; defined as the rate of vasopressor infusion required to prevent spinal hypotension in 50% of subjects) of both drugs needed to maintain maternal systolic blood pressure within 20% of the baseline after spinal anesthesia for cesarean delivery and to derive the relative potency ratio.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Sixty healthy patients undergoing elective cesarean delivery with standardized spinal anesthesia were randomized into 2 groups. The first patient in group 1 received phenylephrine 1200 \u00b5g in normal saline 0.9% w\/v 60 mL at 60 mL\/h infusion rate (20 \u00b5g.min\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). The first patient in group 2 received norepinephrine 96 \u00b5g in normal saline 0.9% w\/v 60 mL at 60 mL\/h infusion rate (1.6 \u00b5g.min\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). Using up-down sequential allocation technique, the vasopressor dose for every subsequent patient was determined by the response in the previous patient. If effective, the next patient received a dose reduced by 150 \u00b5g of phenylephrine (2.5 \u00b5g.min\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) or 12 \u00b5g (0.2 \u00b5g.min\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) of norepinephrine. If ineffective, the dose for the next patient was increased by the same amount. The ED50s were determined according to the Dixon-Massey formula. Stroke volume (SV), HR, and CO were also measured.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The ED\n                      <jats:sub>50<\/jats:sub>\n                      was 12.7 \u00b5g.min\n                      <jats:sup>\u22121<\/jats:sup>\n                      (95% CI, 10.5\u201314.9) for phenylephrine and 1.01 \u00b5g.min\n                      <jats:sup>\u22121<\/jats:sup>\n                      (95% CI, 0.84\u20131.18) for norepinephrine, giving a potency ratio of 12.6 (95% CI, 9.92\u201315.9). HR, SV, and CO did not differ between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Norepinephrine is more potent than phenylephrine by a factor of approximately 13 when administered as infusion for equivalent maternal blood pressure control. Based on these findings, we recommend a variable rate prophylactic infusion of norepinephrine to be initiated at 1.9 to 3.8 \u00b5g.min\n                      <jats:sup>\u2212<\/jats:sup>\n                      1 for the management of hypotension during cesarean delivery under spinal anesthesia.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007231","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:00:59Z","timestamp":1728478859000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Optimal Infusion Rate of Norepinephrine for Prevention of Spinal Hypotension for Cesarean Delivery: A Randomized Controlled Trial, Using Up-Down Sequential Allocation"],"prefix":"10.1213","volume":"141","author":[{"given":"Fatima","family":"Khatoon","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitko","family":"Kocarev","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Fernando","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Naz","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Khalid","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eynas Omer","family":"Ibrahim Abdalla","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malachy","family":"Columb","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Perioperative and Intensive Care Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/anae.14080","article-title":"International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia.","volume":"73","author":"Kinsella","year":"2018","journal-title":"Anaesthesia"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/ALN.0000000000000601","article-title":"Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery.","volume":"122","author":"Ngan Kee","year":"2015","journal-title":"Anesthesiology"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1213\/ANE.0000000000006244","article-title":"Manually controlled, continuous infusion of phenylephrine or norepinephrine for maintenance of blood pressure and cardiac output during spinal anesthesia for cesarean delivery: a double-blinded randomized study.","volume":"136","author":"Belin","year":"2023","journal-title":"Anesth Analg"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0000000000001880","article-title":"A Random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for cesarean delivery.","volume":"127","author":"Ngan Kee","year":"2017","journal-title":"Anesthesiology"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1748-1716.1989.tb08688.x","article-title":"Comparative effects of the alpha-adrenoceptor agonists noradrenaline, phenylephrine and clonidine in the human saphenous vein in vivo and in vitro.","volume":"136","author":"Sj\u00f6berg","year":"1989","journal-title":"Acta Physiol Scand"},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bja\/aei265","article-title":"Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section.","volume":"96","author":"Saravanan","year":"2006","journal-title":"Br J Anaesth"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","article-title":"Advances in and limitations of up- and-down methodology: a pre\u0301cis of clinical use, study design, and dose estimation in anesthesia research.","volume":"107","author":"Pace","year":"2007","journal-title":"Anesthesiology"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.0006-341X.2002.00171.x","article-title":"Dose finding using the biased coin up-and-down design and isotonic regression.","volume":"58","author":"Stylianou","year":"2002","journal-title":"Biometrics"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1213\/ANE.0000000000001846","article-title":"NE intermittent intravenous boluses to prevent hypotension during spinal anesthesia for cesarean delivery: a sequential allocation dose-finding study.","volume":"125","author":"Onwochei","year":"2017","journal-title":"Anesth Analg"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1213\/ANE.0000000000003704","article-title":"Comparison of intermittent intravenous boluses of phenylephrine and norepinephrine to prevent and treat spinal-induced hypotension in cesarean deliveries: Randomized controlled trial.","volume":"129","author":"Sharkey","year":"2019","journal-title":"Anesth Analg"},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/anae.14675","article-title":"A randomised controlled trial of phenylephrine and noradrenaline boluses for treatment of postspinal hypotension during elective caesarean section.","volume":"74","author":"Mohta","year":"2019","journal-title":"Anaesthesia"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.bja.2019.12.019","article-title":"A randomised double-blind dose-response study of weight-adjusted infusions of norepinephrine for preventing hypotension during combined spinal-epidural anaesthesia for Caesarean delivery.","volume":"124","author":"Fu","year":"2020","journal-title":"Br J Anaesth"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ALN.0000000000002483","article-title":"Norepinephrine infusion for preventing postspinal anesthesia hypotension during cesarean delivery: a randomized dose-finding trial.","volume":"130","author":"Hasanin","year":"2019","journal-title":"Anesthesiology"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijoa.2016.08.005","article-title":"An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery.","volume":"29","author":"Vallejo","year":"2017","journal-title":"Int J Obstet Anesth"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12871-020-01145-0","article-title":"Effects of continuous infusion of phenylephrine vs. norepinephrine on parturients and fetuses under LiDCOrapid monitoring: a randomized, double-blind, placebo-controlled study.","volume":"20","author":"Feng","year":"2020","journal-title":"BMC Anesthesiol"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00540-016-2154-9","article-title":"Minimally invasive or noninvasive cardiac output measurement: an update.","volume":"30","author":"Sangkum","year":"2016","journal-title":"J Anesth"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1213\/ANE.0b013e31822649fb","article-title":"The impact of phenylephrine, ephedrine, and increased preload on third-generation Vigileo-FloTrac and esophageal Doppler cardiac output measurements.","volume":"113","author":"Meng","year":"2011","journal-title":"Anesth Analg"},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1213\/ANE.0b013e31829562c3","article-title":"Noninvasive continuous cardiac output by the Nexfin before and after preload-modifying maneuvers: a comparison with intermittent thermodilution cardiac output.","volume":"117","author":"Bubenek-Turconi","year":"2013","journal-title":"Anesth Analg"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bja.2020.05.057","article-title":"Norepinephrine or phenylephrine during spinal anaesthesia for caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome.","volume":"125","author":"Ngan Kee","year":"2020","journal-title":"Br J Anaesth"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0885066616686035","article-title":"Safety of the peripheral administration of vasopressor agents.","volume":"34","author":"Lewis","year":"2019","journal-title":"J Intensive Care Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:18Z","timestamp":1786112838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007231","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}